1-20 of 162
R Storb
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.

B. Bruno, MD, M. Rotta, MD, F. Patriarca, MD, D. Mattei, MD, B. Allione, MD, F. Carnevale-Schianca, MD, A. Rambaldi, MD, M. Casini, MD, V. Montefusco, MD, M. Parma, MD, P. Bavaro, MD, F. Onida, MD, A. Busca, MD, L. Castagna, MD, M.P. Iori, MD, D. Maloney, MD, B. Sandmaier, MD, F. Benedetti, MD, N. Mordini, MD, L. Giaccone, MD, R. Sorasio, MD, F. Fiore, MD, A. Filippi, MD, A. Palumbo, MD, M. Aglietta, MD, A. Levis, MD, R. Foà, MD, P. Di Bartolomeo, MD, E. Pogliani, MD, G. Lambertenghi-Deliliers, MD, M. Falda, MD, M. Petrini, MD, P. Corradini, MD, R. Fanin, MD, U. Ricardi, MD, R. Storb, MD, I. Baldi, B.Sc, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 3026.
https://doi.org/10.1182/blood.V110.11.3026.3026
Published: 2007
Journal Articles

An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma.

B. Bruno, MD, R. Sorasio, MD, F. Patriarca, MD, N. Mordini, MD, B. Allione, MD, F. Carnevale-Schianca, MD, L. Giaccone, MD, M. Rotta, MD, P. Omedè, B.Sc, I. Baldi, B.Sc, S. Bringhen, MD, M. Massaia, MD, M. Aglietta, MD, A. Levis, MD, D. Mattei, MD, R. Fanin, MD, A. Palumbo, MD, R. Storb, MD, G. Ciccone, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 482.
https://doi.org/10.1182/blood.V110.11.482.482
Published: 2007
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.

Frederic Baron, R. Storb, B. Storer, D. Maloney, M. Maris, D. Niederwieser, J. Shizuru, T. Chauncey, B. Bruno, S. Forman, P. McSweeney, R. Maziarz, M. Pulsipher, E. Agura, M. Sorror, J. Wade, B. Sandmaier
Journal: Blood
Blood (2005) 106 (11): 1143.
https://doi.org/10.1182/blood.V106.11.1143.1143
Published: 2005
Journal Articles

Immunologic Recovery after Nonmyeloablative (NM) Conditioning: A Comparison between Related Versus Unrelated Donor Hematopoietic Cell Transplantation (HCT).

Frederic Baron, M. Maris, J. Storek, M. Metcalf, K. White, B. Sandmaier, D. Maloney, R. Storb, M. Boeckh
Journal: Blood
Blood (2005) 106 (11): 1402.
https://doi.org/10.1182/blood.V106.11.1402.1402
Published: 2005
Journal Articles

Double Autologous Transplant Versus Tandem Autologus - Non Myeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma.

B. Bruno, M. Rotta, F. Patriarca, N. Mordini, B. Allione, F. CarnevaleSchianca, L. Giaccone, P. Omedè, R. Sorasio, M. Giarin, P. Falco, M.T. Ambrosini, S. Bringhen, D. Mattei, M. Massaia, A. Palumbo, M. Aglietta, A. Levis, A. Gallamini, R. Fanin, R. Storb, G. Ciccone, M. Boccadoro
Journal: Blood
Blood (2005) 106 (11): 46.
https://doi.org/10.1182/blood.V106.11.46.46
Published: 2005
Journal Articles

Donor NK Cell Engraftment and Overall and Progression-Free Survivals after Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning.

Frederic Baron, T. Gooley, M.T. Little, E. Petersdorf, M. Malkki, D. Maloney, M. Maris, P. Stroup, S. Shin, J. Baker, T. Chauncey, K. Blume, B. Sandmaier, R. Storb
Journal: Blood
Blood (2005) 106 (11): 398.
https://doi.org/10.1182/blood.V106.11.398.398
Published: 2005
Journal Articles

CMV Infection and Disease after Nonmyeloablative (NM) HCT Revisited: Incidence, Risk Factors, Ganciclovir-Related Neutropenia and Outcome.

L. Norasetthada, K. Kirby, B. Sandmaier, D. Maloney, M. Maris, C. Davis, L. Corey, R. Storb, M. Boeckh
Journal: Blood
Blood (2005) 106 (11): 3247.
https://doi.org/10.1182/blood.V106.11.3247.3247
Published: 2005
Journal Articles

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

F. Kerbauy, M. Maris, B. Storer, D. Maloney, D. Niederwieser, E. Agura, M. Pulsipher, T. Chauncey, R. Maziarz, S. Forman, A. Langston, J. Wade, B. Scott, J. Deeg, R. Storb, B. M. Sandmaier
Journal: Blood
Blood (2005) 106 (11): 792.
https://doi.org/10.1182/blood.V106.11.792.792
Published: 2005
Journal Articles

Hematopoietic Cell Transplants (HCT) from HLA-Matched Related (MRD) and Unrelated (URD) Donors for Patients with Hematologic Malignancies Using Low-Dose TBI Conditioning.

Brenda M. Sandmaier, M.B. Maris, D.G. Maloney, T.A. Gooley, J.A. Shizuru, D.W. Niederwieser, T.R. Chauncey, F. Sahebi, E. Agura, R.T. Maziarz, B. Bruno, M. Pulsipher, A.A. Langston, J. Wade, P.A. McSweeney, E. Epner, W. Bethge, S.J. Forman, K.G. Blume, R. Storb
Journal: Blood
Blood (2005) 106 (11): 655.
https://doi.org/10.1182/blood.V106.11.655.655
Published: 2005
Journal Articles

Feasibility and Toxicity of Nonmyeloablative Hematopoietic Cell Transplantation (HCT) with or without Imatinib for Philadelphia Chromosome (Ph+) Acute Lymphoblastic Leukemia (ALL).

L. Norasetthada, M. B. Maris, B. M. Sandmaier, D. G. Maloney, G. Georges, B. Druker, J. Radich, R. Storb
Journal: Blood
Blood (2004) 104 (11): 5056.
https://doi.org/10.1182/blood.V104.11.5056.5056
Published: 2004
Journal Articles

HLA-Matched Related (MRD) or Unrelated Donor (URD) Non-Myeloablative Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Refractory and Relapsed Aggressive Non Hodgkin Lymphoma (NHL).

L. Norasetthada, M. B. Maris, B. M. Sandmaier, T. Gooley, S. Forman, E. Agura, R. T. Maziarz, J. Shizuru, D. Niederwieser, R. Storb, D. G. Maloney
Journal: Blood
Blood (2004) 104 (11): 2307.
https://doi.org/10.1182/blood.V104.11.2307.2307
Published: 2004
Journal Articles

HLA-Matched Unrelated Donor HCT after Nonmyeloablative Conditioning for Patients with Chronic Myeloid Leukemia.

Frederic Baron, M. Maris, B. Sandmaier, B. Storer, M. Stuart, P. McSweeney, J. Radich, M. Pulsipher, E. Agura, E. Petersdorf, S. Heimfeld, T. Chauncey, M.T. Little, D. Maloney, K. Blume, R. Storb
Journal: Blood
Blood (2004) 104 (11): 2755.
https://doi.org/10.1182/blood.V104.11.2755.2755
Published: 2004
Journal Articles

Qualitative and Quantitative Molecular Follow up of Minimal Residual Disease after Non Myeloablative Allografting for Multiple Myeloma.

B. Bruno, M. Ladetto, M. Astolfi, L. Veneziano, L. Cimolin, E. Galletto, G. Pagliano, M. Rotta, N. Mordini, L. Giaccone, P. Omedè, S. Battaglio, R. Storb, M. Boccadoro
Journal: Blood
Blood (2004) 104 (11): 5128.
https://doi.org/10.1182/blood.V104.11.5128.5128
Published: 2004
Journal Articles

Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.

Michael B. Maris, MD, B. M. Sandmaier, MD, B. Storer, PhD, J. Shizuru, MD, PhD, D. Maloney, MD, PhD, E. Agura, MD, PhD, D. Niederwieser, MD, M. Pulsipher, MD, R. T. Maziarz, MD, P. McSweeney, MD, J. Wade, MD, A. Langston, MD, T. Chauncey, MD, B. Bruno, MD, A. Woolfrey, MD, M.T. Little, PhD, K. Blume, MD, R. Storb, MD
Journal: Blood
Blood (2004) 104 (11): 1818.
https://doi.org/10.1182/blood.V104.11.1818.1818
Published: 2004
Journal Articles

Reduced Incidence of Acute and Chronic Graft-versus-Host Disease (GvHD) without Increased Relapse in Patients with High-Risk Myeloid Disorders Given Thymoglobulin (THY) as Part of the Transplant Conditioning Regimen: A Dose-Finding Study.

H. Joachim Deeg, MD, F. R. Appelbaum, MD, B. Storer, PhD, M. Cassarella, B. Scott, MD, G. McDonald, MD, R. Storb, MD
Journal: Blood
Blood (2004) 104 (11): 181.
https://doi.org/10.1182/blood.V104.11.181.181
Published: 2004
Journal Articles

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

H. J. Deeg, H. M. Shulman, J. E. Anderson, E. M. Bryant, T. A. Gooley, J. T. Slattery, C. Anasetti, A. Fefer, R. Storb, F. R. Appelbaum
Journal: Blood
Blood (2000) 95 (4): 1188–1194.
https://doi.org/10.1182/blood.V95.4.1188.004k38_1188_1194
Published: 2000
Journal Articles

Long-Term Follow-up of a Randomized Study Comparing Cyclophosphamide and Total Body Irradiation With Busulfan and Cyclophosphamide for Patients Receiving Allogeneic Marrow Transplants During Chronic Phase of Chronic Myeloid Leukemia

R.A. Clift, J. Radich, F.R. Appelbaum, P. Martin, M.E.D. Flowers, H.J. Deeg, R. Storb, E.D. Thomas
Journal: Blood
Blood (1999) 94 (11): 3960–3962.
https://doi.org/10.1182/blood.V94.11.3960a
Published: 1999
Journal Articles

Long-Term Follow-Up of a Randomized Trial of Two Irradiation Regimens for Patients Receiving Allogeneic Marrow Transplants During First Remission of Acute Myeloid Leukemia

R.A. Clift, C.D. Buckner, F.R. Appelbaum, K.M. Sullivan, R. Storb, E.D. Thomas
Journal: Blood
Blood (1998) 92 (4): 1455–1456.
https://doi.org/10.1182/blood.V92.4.1455
Published: 1998
Journal Articles

Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

J.T. Slattery, R.A. Clift, C.D. Buckner, J. Radich, B. Storer, W.I. Bensinger, E. Soll, C. Anasetti, R. Bowden, E. Bryant, T. Chauncey, H.J. Deeg, K.C. Doney, M. Flowers, T. Gooley, J.A. Hansen, P.J. Martin, G.B. McDonald, R. Nash, E.W. Petersdorf, J.E. Sanders, G. Schoch, P. Stewart, R. Storb, K.M. Sullivan, E.D. Thomas, R.P. Witherspoon, F.R. Appelbaum
Journal: Blood
Blood (1997) 89 (8): 3055–3060.
https://doi.org/10.1182/blood.V89.8.3055
Published: 1997
Journal Articles

Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy

WI Bensinger, CD Buckner, K Shannon-Dorcy, S Rowley, FR Appelbaum, M Benyunes, R Clift, P Martin, T Demirer, R Storb, M Lee, G Schiller
Journal: Blood
Blood (1996) 88 (11): 4132–4138.
https://doi.org/10.1182/blood.V88.11.4132.4132
Published: 1996